Emmaus Life Sciences Inc - Company Profile
Powered by
All the data and insights you need on Emmaus Life Sciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Emmaus Life Sciences Inc Strategy Report
- Understand Emmaus Life Sciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Emmaus Life Sciences Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
29 Jun 2022 | Emmaus Life Sciences Raises USD0.1 Million in Private Placement | Equity Offering | - |
Emmaus Life Sciences Inc |
12 Oct 2021 | Emmaus Life Sciences Enters into Licensing Agreement with Kainos Medicine | Licensing Agreement |
Emmaus Life Sciences Inc
|
Kainos Medicine Inc
|
02 Mar 2021 | Emmaus Life Sciences Enters into Co-Development Agreement with Kainos Medicine | Partnership | - |
Emmaus Life Sciences Inc
Kainos Medicine Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer